Advisory Committee for Pharmaceutical Science and Clinical Pharmacology (formerly called Advisory Committee for Pharmaceutical Science); Notice of Meeting; Cancellation, 16797 [E7-6283]

Download as PDF 16797 Federal Register / Vol. 72, No. 65 / Thursday, April 5, 2007 / Notices ANNUAL BURDEN ESTIMATES—Continued Number of respondents Instrument Program/Project Management (SF–PPR–F) ................................................. Estimated Total Annual Burden Hours: 11,688. In compliance with the requirements of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Administration for Children and Families is soliciting public comment on the specific aspects of the information collection described above. Copies of the proposed collection of information can be obtained and comments may be forwarded by writing to the Administration for Children and Families, Office of Administration, Office of Information Services, 370 L’Enfant Promenade, SW., Washington, DC 20447, Attn: ACF Reports Clearance Officer. E-mail address: infocollection@acf.hhs.gov. All requests should be identified by the title of the information collection. The Department specifically requests comments on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. consideration will be given to comments and suggestions submitted within 60 days of this publication. Dated: April 2, 2007. Robert Sargis, Reports Clearance Officer. [FR Doc. 07–1676 Filed 4–4–07; 8:45 am] Number of responses per respondent 37 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Advisory Committee for Pharmaceutical Science and Clinical Pharmacology (formerly called Advisory Committee for Pharmaceutical Science); Notice of Meeting; Cancellation AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology scheduled for May 1 and 2, 2007, is cancelled. This meeting was announced in the Federal Register of March 16, 2007 (72 FR 12621). FOR FURTHER INFORMATION CONTACT: Victoria Ferretti-Aceto, Center for Drug Evaluation and Research (HFD–21), Food and Drug Administration, 5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), Rockville, MD 20857, 301–827–7001, FAX: 301–827– 6776, e-mail: Victoria.ferrettiaceto@fda.hhs.gov, or FDA Advisory Committee Information Line, 1–800–741–8138 (301–443–0572 in the Washington, DC area), code 3014512539. Please call the Information Line for up-to-date information on this meeting. Dated: March 29, 2007. Randall W. Lutter, Associate Commissioner for Policy and Planning. [FR Doc. E7–6283 Filed 4–4–07; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4184–01–M jlentini on PROD1PC65 with NOTICES Food and Drug Administration Manufacturing Subcommittee of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology (formerly called Advisory Committee for Pharmaceutical Science); Notice of Meeting; Cancellation AGENCY: Food and Drug Administration, HHS. VerDate Aug<31>2005 19:11 Apr 04, 2007 Jkt 211001 PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 Average burden hours per response 1 ACTION: Total burden hours .50 19 Notice. SUMMARY: The meeting of the Manufacturing Subcommittee of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology scheduled for April 30, 2007, is cancelled. This meeting was announced in the Federal Register of March 5, 2007 (72 FR 9767). FOR FURTHER INFORMATION CONTACT: Victoria Ferretti-Aceto, Center for Drug Evaluation and Research (HFD–21), Food and Drug Administration, 5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), Rockville, MD 20857, 301–827–7001, FAX: 301–827– 6776, e-mail: victoria.ferrettiaceto@fda.hhs.gov, or FDA Advisory Committee Information Line, 1–800–741–8138 (301–443–0572 in the Washington, DC area), code 3014512539. Please call the Information Line for up-to-date information on this meeting. Dated: March 29, 2007. Randall W. Lutter, Associate Commissioner for Policy and Planning. [FR Doc. E7–6288 Filed 4–4–07; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Notice of Meeting of the Advisory Committee on Organ Transplantation Health Resources and Services Administration, HHS. AGENCY: SUMMARY: Pursuant to Public Law 92– 463, the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the twelfth meeting of the Advisory Committee on Organ Transplantation (ACOT), Department of Health and Human Services (HHS). The meeting will be held from approximately 9 a.m. to 5:30 p.m. on May 15, 2007, and from 9 a.m. to 3 p.m. on May 16, 2007, at the DoubleTree Hotel & Executive Meeting Center, 1750 Rockville Pike, Rockville, MD 20852. The meeting will be open to the public; however, seating is limited E:\FR\FM\05APN1.SGM 05APN1

Agencies

[Federal Register Volume 72, Number 65 (Thursday, April 5, 2007)]
[Notices]
[Page 16797]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-6283]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Advisory Committee for Pharmaceutical Science and Clinical 
Pharmacology (formerly called Advisory Committee for Pharmaceutical 
Science); Notice of Meeting; Cancellation

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The meeting of the Advisory Committee for Pharmaceutical 
Science and Clinical Pharmacology scheduled for May 1 and 2, 2007, is 
cancelled. This meeting was announced in the Federal Register of March 
16, 2007 (72 FR 12621).

FOR FURTHER INFORMATION CONTACT: Victoria Ferretti-Aceto, Center for 
Drug Evaluation and Research (HFD-21), Food and Drug Administration, 
5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), 
Rockville, MD 20857, 301-827-7001, FAX: 301-827-6776, e-mail: 
Victoria.ferrettiaceto@fda.hhs.gov, or FDA Advisory Committee 
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
area), code 3014512539. Please call the Information Line for up-to-date 
information on this meeting.

    Dated: March 29, 2007.
Randall W. Lutter,
Associate Commissioner for Policy and Planning.
[FR Doc. E7-6283 Filed 4-4-07; 8:45 am]
BILLING CODE 4160-01-S
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.